MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded within the mitochondrial genome. Specifically, it is encoded within the 12S ribosomal RNA gene. It was discovered by Changhan David Lee and colleagues at the University of Southern California in 2015. MOTS-c represents a paradigm shift in our understanding of mitochondrial biology. Mitochondria are not merely passive energy factories. They are active signaling organelles that communicate metabolic status to the rest of the cell and the body.
Unlike nuclear-encoded peptides, MOTS-c is translated directly from mitochondrial DNA (mtDNA). This places it in a unique class of molecules called mitochondria-derived peptides (MDPs) — sometimes called a mitochondria peptide. Other members of this class include humanin and the SHLP (small humanin-like peptide) family. What distinguishes MOTS-c is its primary role as a metabolic regulator of energy metabolism. It is the first mitochondria-derived peptide demonstrated to translocate to the nucleus. Once there, it regulates nuclear gene expression in response to metabolic stress. It helps counter oxidative damage through Nrf2-dependent antioxidant pathways. Long term studies in animal models suggest MOTS-c may slow age-related metabolic decline. For related compounds, see the GH Axis guide.
Research published in Cell Metabolism (Lee et al., 2015) demonstrated that MOTS-c activates the AMPK pathway. It also inhibits the folate cycle and de novo purine biosynthesis. These effects closely mirror the metabolic adaptations induced by aerobic exercise. Subsequent research has expanded MOTS-c's known roles to include mitochondrial biogenesis, anti-inflammatory signaling, and the attenuation of age-related metabolic decline.
?
What does MOTS-c do? MOTS-c is a signal your mitochondria — the energy-producing parts of your cells — send out when they're working hard. Think of it as your cells' way of saying "we're burning fuel efficiently, keep it up." What makes it scientifically fascinating is that it activates many of the same metabolic pathways that exercise does: better blood sugar control, more efficient fat burning, and improved cellular energy management. Researchers are studying it because it appears to decline as we age, which may partly explain why metabolism slows down over time. The question scientists are trying to answer is whether supplementing with MOTS-c can restore some of that youthful metabolic efficiency. For related longevity compounds, see the Best Peptides for Muscle Growth guide.
Lee et al., Cell Metabolism, 2015
MOTS-c's primary mechanism involves the activation of AMP-activated protein kinase (AMPK), the cell's master energy sensor. AMPK is activated when the AMP:ATP ratio rises — a signal that cellular energy is depleted. MOTS-c mimics this signal by inhibiting the folate cycle, which reduces AICAR availability and triggers AMPK phosphorylation at Thr172. Activated AMPK then initiates broad metabolic reprogramming. This includes increased GLUT4 translocation to the cell membrane (enhancing glucose uptake) and activation of fatty acid oxidation via ACC phosphorylation. It also inhibits hepatic gluconeogenesis via FOXO1 suppression and stimulates mitochondrial biogenesis via PGC-1α upregulation.
Kim et al., Nature Communications, 2018
A defining characteristic of MOTS-c is its ability to translocate from the mitochondria to the nucleus in response to metabolic stress. Once in the nucleus, MOTS-c interacts with the antioxidant response element (ARE) and activates Nrf2-dependent gene expression. This upregulates antioxidant enzymes including superoxide dismutase (SOD2), catalase, and glutathione peroxidase. These enzymes directly counteract oxidative stress by neutralizing reactive oxygen species (ROS) generated during metabolic activity. This nuclear signaling function positions MOTS-c as a retrograde signal that communicates mitochondrial metabolic status directly to the genome.
Reynolds et al., Cell Metabolism, 2019
Research published in Cell Metabolism (2019) demonstrated that MOTS-c is secreted into the bloodstream during exercise, acting as a myokine-like signal. Plasma MOTS-c levels increase significantly during aerobic exercise in both rodents and humans, and exogenous MOTS-c administration to sedentary mice improved exercise capacity, reduced adiposity, and enhanced insulin sensitivity — effects comparable to a structured exercise program. This has positioned MOTS-c as a potential 'exercise mimetic' of significant therapeutic interest.
Lee et al., Cell Metabolism, 2021
Circulating MOTS-c levels decline significantly with age in both rodents and humans, correlating with the age-related decline in metabolic flexibility and mitochondrial function. Administration of exogenous MOTS-c to aged mice (24 months) improved grip strength, treadmill performance, and metabolic parameters while reducing markers of systemic inflammation (IL-6, TNF-α). These findings, published in Cell Metabolism (2021), suggest that MOTS-c supplementation may partially reverse the mitochondrial signaling deficits that contribute to age-related metabolic decline.
?
MOTS-c works through a chain reaction that starts in your mitochondria and ends up changing how your entire body handles energy. The key player is AMPK — think of it as a switch that tells your cells "we need to be more efficient." When MOTS-c activates AMPK, your cells get better at pulling glucose out of the blood (which is why researchers are interested in it for insulin resistance), better at burning fat for fuel, and better at building new mitochondria. The really interesting part is that MOTS-c can actually travel from the mitochondria into the cell's nucleus and change which genes are turned on — it's essentially a message from your power plants to your DNA saying "we need to adapt." And because it does all of this naturally during exercise, researchers are studying whether it could provide similar metabolic benefits to people who can't exercise due to age or illness.